Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.55 | 5.306 | 0.56065 | 1.00000 | |
RegionR2 | 2.167 | 5.306 | 0.00002 | 0.00118 | |
RegionR3 | -0.807 | 5.306 | 0.10353 | 0.56330 | |
RegionR4 | -1.48 | 5.306 | 0.00723 | 0.04797 | |
RegionR5 | 0.834 | 5.306 | 0.04130 | 0.16321 | |
RegionR6 | -0.757 | 5.306 | 0.11551 | 0.61977 | |
RegionR7 | 0.366 | 5.306 | 0.45164 | 1.00000 | |
RegionR8 | 0.226 | 5.306 | 0.69898 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.056 | 5.306 | 0.45725 | 1.00000 | |
RegenerationR2 | 1.02 | 5.306 | 0.04009 | 0.33114 | |
RegenerationR3 | -1.26 | 5.306 | 0.03010 | 0.31104 | |
RegenerationR4 | -1.089 | 5.306 | 0.06286 | 0.40115 | |
RegenerationR5 | -1.143 | 5.306 | 0.03095 | 0.29342 | |
RegenerationR6 | -1.131 | 5.306 | 0.06281 | 0.31476 | |
RegenerationBL | -1.397 | 5.306 | 0.03227 | 0.20130 | |
RegenerationTP | -1.034 | 5.306 | 0.09238 | 0.47752 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
2. | MligTC455_09697 | 52 | 1.08 | Mlig455_009478, Mlig455_061921 | Neo: - Age: - |
CD207 | 4.763 | 0.854 | - | 0.958 | 0.984 | 0.989 | 0.978 | Mlig455_009478 {REF} {Length: 1068} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Human: ENSG00000116031, CD207, CD207 molecule, [Score=48.5, Expect=5e-06]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=1e-13]} {RNA1310_33496.1} {RNA815_23317} Mlig455_061921 {REF} {Length: 776} {Pfam: Lectin C-type domain [PF00059.23, score=35.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_33496.1} {RNA815_23317} |
3. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 4.638 | 0.792 | - | 0.966 | 0.959 | 0.981 | 0.940 | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
4. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
4.628 | 0.823 | - | 0.868 | 0.994 | 0.974 | 0.969 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
5. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 4.591 | 0.830 | - | 0.948 | 0.878 | 0.955 | 0.980 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
6. | MligTC455_16875 | 42 | 0.88 | Mlig455_028243 | Neo: - Age: Up-Down-Down |
KCNK16 | 4.568 | 0.852 | - | 0.900 | 0.924 | 0.979 | 0.913 | Mlig455_028243 {REF} {Length: 2676} {Pfam: Ion channel [PF07885.18, score=116.8]; Ion transport protein [PF00520.33, score=28.8]; Protein of unknown function (DUF3112) [PF11309.10, score=19.5]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=97.8, Expect=5e-22]; ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=97.4, Expect=2e-21]; ENSG00000100433, KCNK10, potassium two pore domain channel subfamily K member 10, [Score=94.4, Expect=6e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=102, Expect=4e-23]; ENSMUSG00000023387, Kcnk16, potassium channel, subfamily K, member 16, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0033257, sand, sandman, [Score=150, Expect=2e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=162, Expect=5e-45]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=340, Expect=2e-113]} {RNA1509_39975} {RNA1310_18301.1, RNA1509_39975} {RNA1509_39975, RNA815_12440} |
7. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
4.561 | 0.837 | - | 0.951 | 0.803 | 0.993 | 0.977 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
8. | MligTC455_19042 | 3679 | 76.64 | Mlig455_030661 | Neo: - Age: logFC(26M/2M)=0.480 Region-specific R2: 2.811 Region-enriched R2: 1.755/0.00003 |
CAV1 | 4.546 | 0.781 | - | 0.931 | 0.927 | 0.977 | 0.930 | Mlig455_030661 {REF} {Length: 1257} {Pfam: Caveolin [PF01146.19, score=124.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=105, Expect=2e-29]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=105, Expect=2e-29]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [RH, Score=81.6, Expect=8e-20]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=144, Expect=1e-45]} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1310_31540, RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522, RNA815_14585} |
9. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 4.521 | 0.792 | - | 0.954 | 0.979 | 0.821 | 0.975 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
10. | MligTC455_16874 | 38 | 0.8 | Mlig455_028170 | Neo: - Age: - |
KCNK18 | 4.495 | 0.792 | - | 0.775 | 0.991 | 0.950 | 0.987 | Mlig455_028170 {REF} {Length: 2452} {Pfam: Ion channel [PF07885.18, score=103.1]; Protein of unknown function (DUF3112) [PF11309.10, score=20.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=96.7, Expect=1e-21]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=101, Expect=2e-23]} {Dmel: FBgn0033257, sand, sandman, [Score=129, Expect=2e-33]} {Celegans: WBGene00006680, twk-28, TWiK family of potassium channels, [Score=144, Expect=3e-38]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=270, Expect=2e-87]} {RNA1509_39975} {RNA1310_18301.1} {RNA815_12440} |
11. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
4.494 | 0.831 | - | 0.952 | 0.763 | 0.965 | 0.983 | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
12. | MligTC455_18579 | 143 | 2.97 | Mlig455_047208, Mlig455_048469 | Neo: - Age: - |
GRIK2, GRIK3 | 4.489 | 0.802 | - | 0.938 | 0.994 | 0.776 | 0.979 | Mlig455_047208 {REF} {Length: 5413} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=92.5]; Ligand-gated ion channel [PF00060.28, score=84.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=49.2]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=194, Expect=2e-50]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=193, Expect=5e-50]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=192, Expect=2e-49]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=192, Expect=2e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=191, Expect=3e-49]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=194, Expect=1e-50]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=194, Expect=3e-50]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=191, Expect=2e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=191, Expect=2e-49]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=188, Expect=2e-48]} {Dmel: FBgn0038837, CG3822, [Score=185, Expect=9e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=200, Expect=7e-53]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=341, Expect=5e-106]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308} Mlig455_048469 {REF} {Length: 3740} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.9]; Ligand-gated ion channel [PF00060.28, score=82.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=51.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=190, Expect=6e-50]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=187, Expect=5e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=185, Expect=3e-48]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=184, Expect=1e-47]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=189, Expect=7e-50]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=187, Expect=6e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=185, Expect=2e-48]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=183, Expect=9e-48]} {Dmel: FBgn0038837, CG3822, [Score=183, Expect=4e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=183, Expect=3e-48]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=338, Expect=6e-108]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308} |
13. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 4.452 | 0.808 | - | 0.938 | 0.790 | 0.986 | 0.930 | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
14. | MligTC455_45495 | 988 | 20.58 | Mlig455_010003 | Neo: - Age: logFC(26M/2M)=0.384 Region-enriched R2: 2.517/0.00003 |
CAV2 | 4.424 | 0.717 | - | 0.929 | 0.836 | 0.967 | 0.975 | Mlig455_010003 {REF} {Length: 748} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1} {RNA815_31873} |
15. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 4.419 | 0.733 | - | 0.964 | 0.871 | 0.874 | 0.977 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
16. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
4.388 | 0.803 | - | 0.951 | 0.867 | 0.791 | 0.976 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
17. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
4.355 | 0.797 | 0.904 | 0.911 | 0.765 | - | 0.978 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
18. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 4.336 | 0.792 | - | 0.966 | 0.772 | 0.829 | 0.977 | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
19. | MligTC455_29045 | 127 | 2.65 | Mlig455_056054 | Neo: - Age: - Region-enriched R2: 4.858/0.00652 |
FZD5 | 4.335 | 0.828 | - | 0.788 | 0.978 | 0.760 | 0.981 | Mlig455_056054 {REF} {Length: 3655} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=389.0]; Fz domain [PF01392.24, score=85.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=554, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [Score=561, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=516, Expect=5e-176]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=368, Expect=3e-120]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [Score=522, Expect=7e-178]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
20. | MligTC455_16096 | 69 | 1.44 | Mlig455_059809 | Neo: - Age: - |
ANGPTL1 | 4.323 | - | 0.783 | 0.806 | 0.954 | 0.800 | 0.980 | Mlig455_059809 {REF} {Length: 1391} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=117.9]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=109, Expect=1e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=106, Expect=2e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=110, Expect=3e-27]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=105, Expect=2e-25]} {Dmel: FBgn0003326, sca, scabrous, [Score=91.3, Expect=3e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.2, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=77.8, Expect=5e-16]} {RNA1509_28467} {RNA1310_47262} {RNA815_18070.1} |
21. | MligTC455_42579 | 1841 | 38.34 | Mlig455_061617 | Neo: - Age: - Region-enriched R7: 1.560/0.01513 Regeneration-downregulated BL: -2.445 Regeneration-depleted BL: -2.445 |
CAV2 | 4.317 | 0.792 | - | 0.946 | 0.802 | 0.827 | 0.950 | Mlig455_061617 {REF} {Length: 4295} {Pfam: Caveolin [PF01146.19, score=121.3]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=87.4, Expect=2e-22]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=90.1, Expect=1e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.2, Expect=1e-16]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=144, Expect=2e-45]} {RNA1509_24227} {RNA1310_41576, RNA1509_24227} {RNA1509_24227, RNA815_20166} |
22. | MligTC455_33141 | 65 | 1.36 | Mlig455_033449, Mlig455_040183 | Neo: - Age: Down-Up-Down |
4.232 | 0.817 | - | 0.776 | 0.958 | 0.867 | 0.814 | Mlig455_033449 {REF} {Length: 2524} {RNA1310_22116} {RNA815_34454} Mlig455_040183 {REF} {Length: 2528} {RNA1310_22116} {RNA815_34454} |
|
23. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
4.224 | 0.762 | - | 0.871 | 0.864 | 0.758 | 0.969 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |
|
24. | MligTC455_13095 | 40 | 0.82 | Mlig455_036239 | Neo: - Age: - |
4.208 | 0.817 | - | 0.781 | 0.887 | 0.994 | 0.729 | Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130} | |
25. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 4.188 | 0.790 | - | 0.915 | 0.715 | 0.808 | 0.960 | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
26. | MligTC455_21693 | 48 | 1 | Mlig455_024307, Mlig455_024362, Mlig455_024476 | Neo: - Age: - |
AHR | 4.161 | 0.788 | - | 0.769 | 0.950 | 0.776 | 0.878 | Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588} Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588} Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588} |
27. | MligTC455_13171 | 25 | 0.53 | Mlig455_005963, Mlig455_005967 | Neo: - Age: - |
3.844 | - | - | 0.959 | 0.908 | 0.992 | 0.985 | Mlig455_005963 {REF} {Length: 2617} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} Mlig455_005967 {REF} {Length: 1405} {Pfam: Lectin C-type domain [PF00059.23, score=20.7]} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} |
|
28. | MligTC455_37793 | 353 | 7.36 | Mlig455_066109, Mlig455_068663 | Neo: - Age: Up-Down-Down |
HMCN1 | 3.839 | - | - | 0.951 | 0.955 | 0.951 | 0.982 | Mlig455_066109 {REF} {Length: 7924} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=408.1]; Spondin-like TSP1 domain [PF19028.2, score=285.5]; Polycystin cation channel [PF08016.14, score=239.7]; PLAT/LH2 domain [PF01477.25, score=86.7]; Thrombospondin type 1 domain [PF19030.2, score=78.4]; Ion transport protein [PF00520.33, score=42.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=360, Expect=8e-99]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=363, Expect=7e-100]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=199, Expect=5e-51]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=306, Expect=4e-84]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [RH, Score=944, Expect=0.0]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} Mlig455_068663 {REF} {Length: 7866} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=423.7]; Spondin-like TSP1 domain [PF19028.2, score=299.7]; Thrombospondin type 1 domain [PF19030.2, score=92.3]; PLAT/LH2 domain [PF01477.25, score=23.1]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=338, Expect=1e-94]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=341, Expect=9e-96]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=189, Expect=2e-48]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=303, Expect=2e-84]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=282, Expect=3e-77]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} |
29. | MligTC455_37792 | 210 | 4.38 | Mlig455_024774 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.926 Region-enriched R2: 6.055/0.00271 |
PKD1L2 | 3.83 | - | - | 0.950 | 0.962 | 0.990 | 0.928 | Mlig455_024774 {REF} {Length: 6374} {Pfam: Polycystin cation channel [PF08016.14, score=224.6]; PLAT/LH2 domain [PF01477.25, score=66.8]; Ion transport protein [PF00520.33, score=30.8]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=179, Expect=9e-45]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=187, Expect=3e-47]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=109, Expect=1e-23]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=187, Expect=2e-47]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=902, Expect=0.0]} {RNA1509_46134} {RNA1310_488} {RNA815_1711} |
30. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
3.828 | - | - | 0.959 | 0.923 | 0.964 | 0.982 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
31. | MligTC455_15450 | 19 | 0.39 | Mlig455_006618 | Neo: - Age: - |
3.802 | - | - | 0.951 | 0.912 | 0.954 | 0.985 | Mlig455_006618 {REF} {Length: 653} {Pfam: WSC domain [PF01822.21, score=30.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=7e-09]} {RNA1310_35396.1} {RNA815_56551} | |
32. | MligTC455_08853 | 22 | 0.45 | Mlig455_068998 | Neo: - Age: - |
3.801 | - | - | 0.954 | 0.942 | 0.978 | 0.927 | Mlig455_068998 {REF} {Length: 1981} {Pfam: Glycine rich protein [PF12810.9, score=35.1]} {RNA1310_75162} {RNA815_38988} | |
33. | MligTC455_50344 | 24 | 0.51 | Mlig455_054355 | Neo: - Age: - |
3.795 | 0.837 | - | - | 0.988 | 0.989 | 0.981 | Mlig455_054355 {REF} {Length: 1376} {RNA1310_56750} | |
34. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
3.781 | - | - | 0.975 | 0.840 | 0.981 | 0.985 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
35. | MligTC455_39179 | 44 | 0.91 | Mlig455_052012 | Neo: - Age: Down-Up-Up |
TCTE3 | 3.777 | 0.837 | - | - | 0.999 | 0.959 | 0.982 | Mlig455_052012 {REF} {Length: 1042} {Pfam: Tctex-1 family [PF03645.15, score=42.5]} {Human: ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=65.9, Expect=8e-13]; ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=65.9, Expect=8e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.8, Expect=1e-23]} {RNA1509_34873} {RNA1310_34743} {RNA815_18661} |
36. | MligTC455_45450 | 66 | 1.38 | Mlig455_061622 | Neo: - |
ZIC4 | 3.776 | - | - | 0.814 | 0.993 | 0.986 | 0.983 | Mlig455_061622 {REF} {Length: 1709} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=49.3]; Zinc-finger double domain [PF13465.8, score=44.8]; Zic proteins zinc finger domain [PF18366.3, score=30.5]} {Human: ENSG00000174963, ZIC4, Zic family member 4, [Score=201, Expect=5e-62]; ENSG00000156925, ZIC3, Zic family member 3, [Score=197, Expect=3e-59]; ENSG00000043355, ZIC2, Zic family member 2, [Score=197, Expect=2e-58]; ENSG00000152977, ZIC1, Zic family member 1, [Score=196, Expect=8e-59]; ENSG00000139800, ZIC5, Zic family member 5, [Score=194, Expect=1e-56]} {Mouse: ENSMUSG00000041703, Zic5, zinc finger protein of the cerebellum 5, [Score=199, Expect=9e-59]; ENSMUSG00000036972, Zic4, zinc finger protein of the cerebellum 4, [Score=197, Expect=9e-61]; ENSMUSG00000067860, Zic3, zinc finger protein of the cerebellum 3, [Score=197, Expect=2e-59]; ENSMUSG00000032368, Zic1, zinc finger protein of the cerebellum 1, [Score=196, Expect=5e-59]; ENSMUSG00000061524, Zic2, zinc finger protein of the cerebellum 2, [Score=196, Expect=1e-58]} {Dmel: FBgn0003002, opa, odd paired, [Score=194, Expect=5e-57]} {Celegans: WBGene00004335, ref-2, REgulator of Fusion, [Score=171, Expect=3e-51]} {Smed: dd_Smed_v6_15531_0_1, dd_Smed_v6_15531_0_1, [Score=214, Expect=4e-66]} {RNA1310_23362} {RNA815_19034} |
37. | MligTC455_17464 | 409 | 8.52 | Mlig455_048989, Mlig455_049006, Mlig455_067762 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.512 Regeneration-downregulated BL: -7.800 Regeneration-depleted BL: -7.800 |
3.773 | - | - | 0.949 | 0.933 | 0.909 | 0.982 | Mlig455_048989 {REF} {Length: 1272} {RNA1310_37715} {RNA815_39767} Mlig455_049006 {REF} {Length: 1028} {RNA1310_37715} {RNA815_39767} Mlig455_067762 {REF} {Length: 1353} {RNA1310_37715} {RNA815_39767} |
|
38. | MligTC455_39047 | 39 | 0.81 | Mlig455_037921, Mlig455_038983 | Neo: - Age: - |
TNN | 3.773 | - | - | 0.886 | 0.973 | 0.938 | 0.976 | Mlig455_037921 {REF} {Length: 4077} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=111.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=95.5, Expect=1e-21]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=94.7, Expect=2e-21]} {Dmel: FBgn0050280, CG30280, [Score=87.0, Expect=3e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_16377} {RNA1310_5710.1} {RNA815_14744.1} Mlig455_038983 {REF} {Length: 2023} {RNA1310_108685} {RNA815_54007} |
39. | MligTC455_13963 | 31 | 0.64 | Mlig455_052027 | Neo: - Age: Down-Up-Down |
3.769 | 0.837 | - | 0.974 | 0.973 | - | 0.985 | Mlig455_052027 {REF} {Length: 1717} {RNA1509_48973} {RNA1310_34931} {RNA815_59614} | |
40. | MligTC455_15948 | 25 | 0.51 | Mlig455_007630 | Neo: - Age: - |
3.768 | - | - | 0.942 | 0.878 | 0.963 | 0.985 | Mlig455_007630 {REF} {Length: 1759} {Pfam: WSC domain [PF01822.21, score=54.5]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-07]} {RNA1509_57286} {RNA1310_33352.2} {RNA815_14158.1} | |
41. | MligTC455_39180 | 256 | 5.34 | Mlig455_057231 | Neo: - Age: logFC(26M/2M)=-0.449 |
TCTE3 | 3.764 | 0.812 | - | - | 0.973 | 0.995 | 0.984 | Mlig455_057231 {REF} {Length: 1057} {Pfam: Tctex-1 family [PF03645.15, score=43.3]} {Human: ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.2, Expect=2e-11]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=59.3, Expect=1e-10]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=59.3, Expect=1e-10]; ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=58.5, Expect=2e-10]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.4, Expect=2e-23]} {RNA1509_34873, RNA1509_48552} {RNA1310_34743, RNA1509_34873, RNA1509_48552} {RNA1509_34873, RNA1509_48552, RNA815_18661} |
42. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 3.763 | - | - | 0.883 | 0.905 | 0.992 | 0.983 | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |
43. | MligTC455_13885 | 28 | 0.58 | Mlig455_020919 | Neo: - Age: - |
3.762 | - | - | 0.799 | 0.999 | 0.979 | 0.985 | Mlig455_020919 {REF} {Length: 1208} {RNA1310_25040.4} {RNA815_12562.1} | |
44. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 3.76 | - | - | 0.987 | 0.809 | 0.980 | 0.984 | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
45. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 3.757 | - | - | 0.919 | 0.958 | 0.951 | 0.929 | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
46. | MligTC455_19064 | 1659 | 34.56 | Mlig455_029479 | Neo: - Age: logFC(26M/2M)=-0.425 Region-enriched R2: 4.582/0.01945 |
MOXD1 | 3.747 | - | - | 0.905 | 0.984 | 0.974 | 0.884 | Mlig455_029479 {REF} {Length: 2454} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=57.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=55.7]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=85.1, Expect=1e-16]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=95.1, Expect=5e-20]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=82.0, Expect=6e-16]} {RNA1509_10910, RNA1509_383, RNA1509_4965, RNA1509_52547, RNA1509_7121} {RNA1310_17053.1, RNA1509_10910, RNA1509_4965, RNA1509_52547, RNA1509_7121} {RNA1509_10910, RNA1509_4965, RNA1509_52547, RNA1509_7121, RNA815_3799} |
47. | MligTC455_21580 | 101 | 2.11 | Mlig455_032452 | Neo: - Age: - |
WSCD2 | 3.743 | - | - | 0.968 | 0.894 | 0.995 | 0.886 | Mlig455_032452 {REF} {Length: 945} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=3e-07]; ENSG00000179314, WSCD1, WSC domain containing 1, [Score=51.2, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.8, Expect=9e-08]} {RNA1310_78298} {RNA815_49767} |
48. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
3.743 | 0.820 | - | 0.955 | 0.986 | - | 0.982 | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
49. | MligTC455_46708 | 362 | 7.53 | Mlig455_045334 | Neo: - Age: - Region-enriched R2: 2.783/0.01800 |
3.741 | - | - | 0.913 | 0.933 | 0.955 | 0.940 | Mlig455_045334 {REF} {Length: 1243} {RNA1509_51601} {RNA1310_43115.2, RNA1509_51601} {RNA1509_51601, RNA815_21402.1} | |
50. | MligTC455_40751 | 206 | 4.29 | Mlig455_045754 | Neo: - Age: Down-Up-Down |
3.738 | - | - | 0.973 | 0.916 | 0.978 | 0.871 | Mlig455_045754 {REF} {Length: 1094} {Pfam: Lectin C-type domain [PF00059.23, score=30.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=55.1, Expect=4e-09]} {RNA1310_36556.1} {RNA815_16968} | |
51. | MligTC455_43961 | 30 | 0.62 | Mlig455_027626 | Neo: - Age: - |
3.733 | - | - | 0.836 | 0.970 | 0.948 | 0.979 | Mlig455_027626 {REF} {Length: 602} {Pfam: PAN domain [PF00024.28, score=26.5]; PAN domain [PF14295.8, score=21.8]} {RNA1310_35396.1} {RNA815_23500} | |
52. | MligTC455_50546 | 21 | 0.44 | Mlig455_045408 | Neo: - Age: - |
3.73 | - | 0.844 | 0.937 | - | 0.995 | 0.954 | Mlig455_045408 {REF} {Length: 1345} {RNA1310_102440} | |
53. | MligTC455_11229 | 51 | 1.06 | Mlig455_054212 | Neo: - Age: - |
3.73 | - | - | 0.958 | 0.799 | 0.989 | 0.984 | Mlig455_054212 {REF} {Length: 1481} {RNA1310_23944} {RNA815_32018} | |
54. | MligTC455_34498 | 36 | 0.75 | Mlig455_029862 | Neo: - Age: - |
NPLOC4 | 3.729 | - | - | 0.951 | 0.827 | 0.970 | 0.981 | Mlig455_029862 {REF} {Length: 1491} {TRANSSPLICED} {Pfam: NPL4 family, putative zinc binding region [PF05020.17, score=77.9]} {Human: ENSG00000182446, NPLOC4, NPL4 homolog, ubiquitin recognition factor, [Score=98.2, Expect=1e-21]} {Mouse: ENSMUSG00000039703, Nploc4, NPL4 homolog, ubiquitin recognition factor, [Score=102, Expect=3e-23]} {Celegans: WBGene00019121, npl-4.2, NPL (Yeast Nuclear Protein Localization) homolog, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_5277_0_1, dd_Smed_v6_5277_0_1, [Score=102, Expect=1e-23]} {RNA1509_6797} {RNA1310_13992} {RNA815_5567} |
55. | MligTC455_44177 | 70 | 1.46 | Mlig455_022828, Mlig455_022920 | Neo: - Age: - |
TNKS | 3.701 | - | - | 0.940 | 0.961 | 0.903 | 0.897 | Mlig455_022828 {REF} {Length: 1654} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=58.3]; Ankyrin repeats (many copies) [PF13637.8, score=51.4]; Ankyrin repeats (many copies) [PF13857.8, score=43.5]; Ankyrin repeat [PF00023.32, score=38.9]; Ankyrin repeat [PF13606.8, score=35.6]} {Dmel: FBgn0039955, CG41099, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.1, Expect=4e-07]} {Smed: dd_Smed_v6_11252_0_1, dd_Smed_v6_11252_0_1, [Score=50.8, Expect=1e-06]} {RNA1509_39040} {RNA1310_886.1} {RNA815_14632} Mlig455_022920 {REF} {Length: 1424} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=65.4]; Ankyrin repeats (3 copies) [PF12796.9, score=61.1]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeat [PF13606.8, score=50.1]; Ankyrin repeat [PF00023.32, score=49.7]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=56.2, Expect=9e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000285372, AC270292.3, tankyrase, [Score=55.5, Expect=2e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=54.3, Expect=3e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=53.5, Expect=8e-07]} {Mouse: ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=56.6, Expect=3e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=56.6, Expect=3e-08]; ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=56.2, Expect=3e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=56.2, Expect=6e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.1, Expect=2e-07]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.1, Expect=2e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=54.3, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=53.9, Expect=2e-07]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0040752, Prosap, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_2072_0_20, dd_Smed_v6_2072_0_20, [Score=59.3, Expect=3e-09]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
56. | MligTC455_39985 | 28 | 0.58 | Mlig455_022339, Mlig455_022351 | Neo: - Age: - |
3.697 | - | - | 0.943 | 0.868 | 0.901 | 0.985 | Mlig455_022339 {REF} {Length: 783} {RNA1509_47318} {RNA1310_125793} {RNA815_2914.1} Mlig455_022351 {REF} {Length: 1105} {Pfam: WSC domain [PF01822.21, score=64.2]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=8e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=51.6, Expect=2e-07]} {RNA1310_59980.1} {RNA815_55549} |
|
57. | MligTC455_27313 | 61 | 1.27 | Mlig455_031814, Mlig455_047613 | Neo: - Age: - |
WSCD2 | 3.696 | 0.837 | - | 0.968 | 0.911 | - | 0.980 | Mlig455_031814 {REF} {Length: 844} {Pfam: WSC domain [PF01822.21, score=66.1]; PAN domain [PF00024.28, score=19.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=62.0, Expect=7e-11]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=1e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=56.6, Expect=3e-09]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=48.5, Expect=1e-06]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} Mlig455_047613 {REF} {Length: 843} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=5e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=4e-07]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} |
58. | MligTC455_47905 | 56 | 1.16 | Mlig455_037694 | Neo: - Age: - |
3.692 | - | - | 0.794 | 0.945 | 0.974 | 0.979 | Mlig455_037694 {REF} {Length: 2503} {RNA1310_36768.1} {RNA815_27683} | |
59. | MligTC455_41339 | 61 | 1.27 | Mlig455_021120 | Neo: - Age: - |
3.688 | - | - | 0.915 | 0.993 | 0.799 | 0.981 | Mlig455_021120 {REF} {Length: 294} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_118897} {RNA815_62550} | |
60. | MligTC455_22150 | 189 | 3.94 | Mlig455_054947 | Neo: - |
XDH | 3.684 | - | - | 0.805 | 0.961 | 0.978 | 0.940 | Mlig455_054947 {REF} {Length: 5481} {Pfam: Molybdopterin-binding domain of aldehyde dehydrogenase [PF02738.20, score=346.4]; [2Fe-2S] binding domain [PF01799.22, score=95.7]; FAD binding domain in molybdopterin dehydrogenase [PF00941.23, score=91.5]; CO dehydrogenase flavoprotein C-terminal domain [PF03450.19, score=51.5]; Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain [PF01315.24, score=47.3]; 2Fe-2S iron-sulfur cluster binding domain [PF00111.29, score=25.1]} {Human: ENSG00000158125, XDH, xanthine dehydrogenase, [Score=476, Expect=9e-146]} {Mouse: ENSMUSG00000024066, Xdh, xanthine dehydrogenase, [Score=471, Expect=4e-144]; ENSMUSG00000079554, Aox2, aldehyde oxidase 2, [Score=457, Expect=7e-139]; ENSMUSG00000063558, Aox1, aldehyde oxidase 1, [Score=456, Expect=1e-138]; ENSMUSG00000038242, Aox4, aldehyde oxidase 4, [Score=449, Expect=5e-136]} {Dmel: FBgn0267408, AOX1, Aldehyde oxidase 1, [Score=640, Expect=0.0]} {Celegans: WBGene00010083, xhd-1, [Score=485, Expect=1e-149]} {RNA1509_325, RNA1509_38160} {RNA1310_1603.1, RNA1509_38160} {RNA1509_38160, RNA815_224.2} |
61. | MligTC455_18682 | 1190 | 24.79 | Mlig455_037756 | Neo: - Age: Up-Down-Down Region-specific R2: 4.877 Region-enriched R2: 4.609/0.00000 |
3.683 | - | - | 0.962 | 0.821 | 0.919 | 0.981 | Mlig455_037756 {REF} {Length: 1188} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
62. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
3.682 | - | - | 0.931 | 0.775 | 0.992 | 0.984 | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
63. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.675 | - | - | 0.853 | 0.931 | 0.920 | 0.971 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
64. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
3.667 | 0.761 | - | 0.943 | - | 0.981 | 0.982 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
65. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 3.666 | - | - | 0.747 | 0.972 | 0.989 | 0.958 | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
66. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 3.665 | 0.837 | - | 0.959 | 0.885 | - | 0.984 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
67. | MligTC455_46880 | 44 | 0.91 | Mlig455_046271 | Neo: - Age: - |
IAH1 | 3.664 | 0.837 | - | 0.899 | 0.957 | - | 0.971 | Mlig455_046271 {REF} {Length: 1061} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=75.8]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.0]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=138, Expect=2e-39]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=121, Expect=4e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=111, Expect=8e-30]} {RNA1310_130726} |
68. | MligTC455_14904 | 4225 | 88.01 | Mlig455_037596 | Neo: - Age: logFC(26M/2M)=0.385 Region-enriched R8: 1.541/0.00053 |
3.663 | - | - | 0.890 | 0.884 | 0.955 | 0.934 | Mlig455_037596 {REF} {Length: 2914} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=59.3, Expect=3e-09]} {RNA1509_17730, RNA1509_4337} {RNA1310_7259, RNA1509_17730} {RNA1509_17730, RNA815_206} | |
69. | MligTC455_50589 | 29 | 0.61 | Mlig455_010626, Mlig455_010716 | Neo: - Age: Down-Up-Down |
3.652 | - | - | 0.729 | 0.988 | 0.961 | 0.974 | Mlig455_010626 {REF} {Length: 2021} {Pfam: Tctex-1 family [PF03645.15, score=27.5]} {RNA1310_36440} Mlig455_010716 {REF} {Length: 2038} {Pfam: Tctex-1 family [PF03645.15, score=27.2]} {RNA1310_36440} |
|
70. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 3.651 | - | - | 0.940 | 0.793 | 0.933 | 0.985 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
71. | MligTC455_13905 | 34 | 0.71 | Mlig455_023395 | Neo: - Age: - |
3.645 | - | - | 0.770 | 0.970 | 0.961 | 0.944 | Mlig455_023395 {REF} {Length: 1110} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [Score=47.0, Expect=2e-06]} {RNA1509_18233} {RNA1310_51675} {RNA815_25040} | |
72. | MligTC455_14716 | 29 | 0.61 | Mlig455_043633 | Neo: - Age: - |
ANGPTL2 | 3.64 | - | - | 0.920 | 0.964 | 0.778 | 0.978 | Mlig455_043633 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=157.6]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=2e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=133, Expect=4e-35]; ENSG00000085265, FCN1, ficolin 1, [Score=132, Expect=8e-36]; ENSG00000160339, FCN2, ficolin 2, [Score=128, Expect=4e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=119, Expect=6e-32]} {Celegans: WBGene00017013, ensh-1, [Score=57.8, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=1e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
73. | MligTC455_43690 | 262 | 5.46 | Mlig455_035029, Mlig455_053437 | Neo: - Age: - Region-enriched R2: 6.108/0.00708 |
WSCD2 | 3.638 | - | - | 0.954 | 0.999 | 0.982 | 0.703 | Mlig455_035029 {REF} {Length: 893} {Pfam: WSC domain [PF01822.21, score=50.2]; PAN domain [PF00024.28, score=29.7]} {RNA1310_42429} {RNA815_24291.1} Mlig455_053437 {REF} {Length: 972} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=29.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=44.7, Expect=1e-05]} {RNA1310_42429} {RNA815_24291.1} |
74. | MligTC455_34475 | 78 | 1.63 | Mlig455_046323, Mlig455_068223 | Neo: - Age: - |
3.624 | - | - | 0.949 | 0.974 | 0.813 | 0.888 | Mlig455_046323 {REF} {Length: 3665} {Smed: dd_Smed_v6_13778_0_1, dd_Smed_v6_13778_0_1, [RH, Score=66.6, Expect=7e-11]} {RNA1310_10926} {RNA815_30720} Mlig455_068223 {REF} {Length: 2793} {Smed: dd_Smed_v6_13778_0_1, dd_Smed_v6_13778_0_1, [RH, Score=65.9, Expect=8e-11]} {RNA1310_10926} {RNA815_30720} |
|
75. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
3.619 | 0.746 | - | - | 0.919 | 0.974 | 0.980 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
76. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 3.619 | - | - | 0.909 | 0.770 | 0.961 | 0.979 | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
77. | MligTC455_50643 | 38 | 0.8 | Mlig455_007952, Mlig455_008053 | Neo: - Age: - |
VSX1 | 3.618 | - | - | 0.742 | 0.988 | 0.910 | 0.978 | Mlig455_007952 {REF} {Length: 1358} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} Mlig455_008053 {REF} {Length: 2271} {RNA1310_76393} {RNA815_51313} |
78. | MligTC455_52482 | 22 | 0.46 | Mlig455_042671 | Neo: - Age: - |
3.603 | - | - | 0.956 | 0.803 | 0.901 | 0.943 | Mlig455_042671 {REF} {Length: 2390} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.1]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=6e-13]} {RNA1310_47540} {RNA815_16144} | |
79. | MligTC455_23621 | 323 | 6.72 | Mlig455_039694, Mlig455_039749 | Neo: - Age: - Region-enriched R2: 2.235/0.02499 |
3.598 | - | - | 0.804 | 0.905 | 0.920 | 0.969 | Mlig455_039694 {REF} {Length: 2054} {RNA1509_29694} {RNA1310_14789} {RNA815_12997} Mlig455_039749 {REF} {Length: 1751} {RNA1509_29694} {RNA1310_14789, RNA1509_29694} {RNA1509_29694, RNA815_12997} |
|
80. | MligTC455_40325 | 103 | 2.15 | Mlig455_013035 | Neo: - Age: - |
3.597 | - | - | 0.849 | 0.899 | 0.864 | 0.985 | Mlig455_013035 {REF} {Length: 653} {RNA1509_20946} {RNA1310_44606} {RNA815_35640} | |
81. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 3.596 | 0.702 | - | 0.944 | - | 0.986 | 0.964 | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
82. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
3.594 | 0.837 | - | 0.874 | 0.898 | - | 0.985 | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
83. | MligTC455_20142 | 488 | 10.17 | Mlig455_036513 | Neo: - |
3.593 | - | - | 0.847 | 0.957 | 0.877 | 0.912 | Mlig455_036513 {REF} {Length: 1074} {NoTransDecoderORF} {RNA1509_4350} {RNA1310_20554, RNA1509_4350} {RNA1509_4350, RNA815_8810.1} | |
84. | MligTC455_46395 | 870 | 18.13 | Mlig455_069471 | Neo: - Age: logFC(26M/2M)=0.458 |
PKD2 | 3.592 | - | - | 0.820 | 0.943 | 0.849 | 0.980 | Mlig455_069471 {REF} {Length: 3122} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.8]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=753, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=750, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=8e-123]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
85. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 3.589 | - | - | 0.968 | 0.892 | 0.745 | 0.984 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
86. | MligTC455_41328 | 417 | 8.68 | Mlig455_057091 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.162/0.00002 |
3.589 | 0.844 | - | 0.909 | - | 0.860 | 0.976 | Mlig455_057091 {REF} {Length: 854} {RNA1310_89414} {RNA815_40489.2} | |
87. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
3.587 | - | - | 0.885 | 0.909 | 0.834 | 0.959 | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
88. | MligTC455_32452 | 209 | 4.35 | Mlig455_029642 | Neo: - Age: - |
PKD1L2 | 3.586 | - | - | 0.762 | 0.949 | 0.895 | 0.980 | Mlig455_029642 {REF} {Length: 12740} {Pfam: Polycystin cation channel [PF08016.14, score=219.7]; REJ domain [PF02010.17, score=146.9]; PKD domain [PF00801.22, score=43.1]; PLAT/LH2 domain [PF01477.25, score=39.5]; Ion transport protein [PF00520.33, score=33.9]; PKD domain [PF18911.2, score=26.0]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=137, Expect=4e-31]; ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=136, Expect=4e-31]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=131, Expect=1e-29]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=191, Expect=1e-47]; ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=182, Expect=5e-45]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=184, Expect=8e-46]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=281, Expect=4e-75]} {RNA1509_5774} {RNA1310_70.1} {RNA815_41} |
89. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 3.577 | 0.825 | - | 0.914 | - | 0.858 | 0.980 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
90. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 3.574 | - | - | 0.826 | 0.833 | 0.940 | 0.975 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
91. | MligTC455_16059 | 116 | 2.42 | Mlig455_044225 | Neo: - Age: - |
CFAP157 | 3.569 | - | - | 0.784 | 0.928 | 0.974 | 0.883 | Mlig455_044225 {REF} {Length: 2823} {Pfam: Siphovirus Gp157 [PF05565.13, score=19.9]} {Human: ENSG00000160401, CFAP157, cilia and flagella associated protein 157, [Score=107, Expect=3e-24]} {Mouse: ENSMUSG00000038987, Cfap157, cilia and flagella associated protein 157, [Score=110, Expect=4e-25]} {Dmel: FBgn0036962, CG17122, [Score=67.4, Expect=2e-11]} {Smed: dd_Smed_v6_11523_0_1, dd_Smed_v6_11523_0_1, [Score=62.0, Expect=4e-10]} {RNA1509_42697} {RNA1310_10711} {RNA815_24261} |
92. | MligTC455_47874 | 67 | 1.4 | Mlig455_000340 | Neo: - Age: - |
3.56 | - | - | 0.941 | 0.978 | 0.940 | 0.701 | Mlig455_000340 {REF} {Length: 1412} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=97.4, Expect=9e-26]} {RNA1509_55952} {RNA1310_12426} {RNA815_33214} | |
93. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 3.558 | - | - | 0.917 | 0.920 | 0.764 | 0.957 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
94. | MligTC455_44300 | 1386 | 28.88 | Mlig455_000467 | Neo: - Age: - Region-enriched R2: 1.856/0.03510 |
3.558 | - | - | 0.813 | 0.955 | 0.938 | 0.852 | Mlig455_000467 {REF} {Length: 459} {NoTransDecoderORF} {RNA1509_16536} {RNA1310_30744} {RNA815_13864} | |
95. | MligTC455_20722 | 36 | 0.74 | Mlig455_001696, Mlig455_066078, Mlig455_066120 | Neo: - Age: - |
3.554 | - | - | 0.884 | 0.769 | 0.932 | 0.969 | Mlig455_001696 {REF} {Length: 1535} {RNA1310_134737} {RNA815_57224} Mlig455_066078 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_134737} {RNA815_57224} Mlig455_066120 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=25.9]} {RNA1310_134737} {RNA815_57224} |
|
96. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
3.549 | 0.826 | - | 0.928 | 0.823 | - | 0.972 | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
97. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
3.548 | 0.807 | - | 0.771 | - | 0.986 | 0.984 | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
98. | MligTC455_33812 | 919 | 19.14 | Mlig455_051682 | Neo: - Age: - Region-enriched R2: 3.553/0.00065 |
MOXD1 | 3.546 | 0.808 | 0.757 | - | 0.993 | 0.988 | - | Mlig455_051682 {REF} {Length: 2654} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=93.8]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=68.4]; Proline-rich membrane anchor 1 [PF16101.7, score=18.9]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=120, Expect=2e-28]; ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=117, Expect=2e-27]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=135, Expect=1e-33]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=129, Expect=8e-32]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=139, Expect=2e-35]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=119, Expect=1e-29]} {RNA1509_127, RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801} {RNA1310_9934.2, RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801} {RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801, RNA815_4383.1} |
99. | MligTC455_09456 | 47 | 0.97 | Mlig455_029993 | Neo: - Age: - Region-enriched R2: 5.041/0.00960 |
3.543 | 0.821 | - | 0.845 | - | 0.901 | 0.976 | Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870} | |
100. | MligTC455_22686 | 26 | 0.55 | Mlig455_000566, Mlig455_030366 | Neo: - Age: - |
GRIK3 | 3.539 | - | - | 0.911 | 0.915 | 0.762 | 0.951 | Mlig455_000566 {REF} {Length: 2943} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=52.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=5e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=6e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=154, Expect=7e-38]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=152, Expect=2e-37]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=2e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=4e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=4e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=155, Expect=5e-39]} {RNA1310_20394.1} {RNA815_45848} Mlig455_030366 {REF} {Length: 2933} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=51.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=4e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=5e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=152, Expect=2e-37]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=3e-35]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=144, Expect=9e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=5e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=5e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=154, Expect=1e-38]} {RNA1310_20394.1} {RNA815_45848} |